Current status of genetic modification of T cells for cancer treatment

ISSN： 1465-3249

Source： Cytotherapy, Vol.7, Iss.3, 2005-07, pp. : 262-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stemness or Not Stemness? Current Status and Perspectives of Adult Retinal Stem Cells

Current Stem Cell Research & Therapy, Vol. 4, Iss. 2, 2009-05 ,pp. : 118-130

Bentham Science Publishers

Access to resources Recommend Favorite

The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML

By Bunjes D

Cytotherapy, Vol. 3, Iss. 3, 2001-05 ,pp. : 175-188

Ashgate Publishing Ltd

Access to resources Recommend Favorite

GMP production and testing of Xcellerated T Cells™ for the treatment of patients with CLL

By Hami LS Green C Leshinsky N Markham E Miller K Craig S

Cytotherapy, Vol. 6, Iss. 6, 2004-12 ,pp. : 554-562

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Manipulating regulatory T cells

By Barrett Aj

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 109-110

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer

By Rancourt C Bergeron C Lane D Garon G Piché A

Cytotherapy, Vol. 5, Iss. 6, 2003-12 ,pp. : 509-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite